相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pharmacokinetics and pharmacodynamics of various glucagon dosages at different blood glucose levels
H. Blauw et al.
DIABETES OBESITY & METABOLISM (2016)
Day-and-Night Closed-Loop Glucose Control in Patients With Type 1 Diabetes Under Free-Living Conditions: Results of a Single-Arm 1-Month Experience Compared With a Previously Reported Feasibility Study of Evening and Night at Home
Eric Renard et al.
DIABETES CARE (2016)
Effects of subcutaneous, low-dose glucagon on insulin-induced mild hypoglycaemia in patients with insulin pump treated type 1 diabetes
A. Ranjan et al.
DIABETES OBESITY & METABOLISM (2016)
Performance and safety of an integrated bihormonal artificial pancreas for fully automated glucose control at home
H. Blauw et al.
DIABETES OBESITY & METABOLISM (2016)
Heart failure outcomes with empagliflozin in patients with type 2 diabetes at high cardiovascular risk: results of the EMPA-REG OUTCOME® trial
David Fitchett et al.
EUROPEAN HEART JOURNAL (2016)
Single- and Dual-Hormone Artificial Pancreas for Overnight Glucose Control in Type 1 Diabetes
Ahmad Haidar et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
Day and night glycaemic control with a bionic pancreas versus conventional insulin pump therapy in preadolescent children with type 1 diabetes: a randomised crossover trial
Steven J. Russell et al.
LANCET DIABETES & ENDOCRINOLOGY (2016)
Sleep disorders, obesity, and aging: The role of orexin
Joshua P. Nixon et al.
AGEING RESEARCH REVIEWS (2015)
Effect of Repeated Glucagon Doses on Hepatic Glycogen in Type 1 Diabetes: Implications for a Bihormonal Closed-Loop System
Jessica R. Castle et al.
DIABETES CARE (2015)
Inhibition of the glucose transporter SGLT2 with dapagliflozin in pancreatic alpha cells triggers glucagon secretion
Caroline Bonner et al.
NATURE MEDICINE (2015)
Home Use of an Artificial Beta Cell in Type 1 Diabetes
H. Thabit et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Glucagon Increases Beating Rate but Not Contractility in Rat Right Atrium. Comparison with Isoproterenol
Beatriz Merino et al.
PLOS ONE (2015)
Outpatient overnight glucose control with dual-hormone artificial pancreas, single-hormone artificial pancreas, or conventional insulin pump therapy in children and adolescents with type 1 diabetes: an open-label, randomised controlled trial
Ahmad Haidar et al.
LANCET DIABETES & ENDOCRINOLOGY (2015)
When you come to a fork in the road, take it!
Steven J. Russell
LANCET DIABETES & ENDOCRINOLOGY (2015)
2 month evening and night closed-loop glucose control in patients with type 1 diabetes under free-living conditions: a randomised crossover trial
Jort Kropff et al.
LANCET DIABETES & ENDOCRINOLOGY (2015)
A comparison of low-dose ACTH, glucagon stimulation and insulin tolerance test in patients with pituitary disorders
Y. Simsek et al.
CLINICAL ENDOCRINOLOGY (2015)
The influence of glucagon on postprandial hyperglycaemia in children 5 years after onset of type 1 diabetes
Siri Fredheim et al.
DIABETOLOGIA (2015)
Interleukin-6 amplifies glucagon secretion: coordinated control via the brain and pancreas
Tammy M. Barnes et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2014)
Lifestyle and Cardiometabolic Risk in Adults with Type 1 Diabetes: A Review
Catherine Leroux et al.
CANADIAN JOURNAL OF DIABETES (2014)
Treatment for calcium channel blocker poisoning: A systematic review
M. St-Onge et al.
CLINICAL TOXICOLOGY (2014)
Glucagon Response to Oral Glucose Challenge in Type 1 Diabetes: Lack of Impact of Euglycemia. Diabetes Care 2014;37:1076-1082
Caroline K. Kramer et al.
DIABETES CARE (2014)
Quantification of the Glycemic Response to Microdoses of Subcutaneous Glucagon at Varying Insulin Levels
Joseph El Youssef et al.
DIABETES CARE (2014)
Intestinal glucose metabolism revisited
Gilles Mithieux et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2014)
Biochemical Stabilization of Glucagon at Alkaline pH
Nicholas Caputo et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2014)
Glucagon regulates orexin A secretion in humans and rodents
Ayman M. Arafat et al.
DIABETOLOGIA (2014)
Outpatient Glycemic Control with a Bionic Pancreas in Type 1 Diabetes
Steven J. Russell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Glucagon Stimulates Hepatic FGF21 Secretion through a PKA- and EPAC-Dependent Posttranscriptional Mechanism
Holly A. Cyphert et al.
PLOS ONE (2014)
Glucose-responsive insulin and glucagon delivery (dual-hormone artificial pancreas) in adults with type 1 diabetes: a randomized crossover controlled trial
Ahmad Haidar et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2013)
Role of KATP Channels in Glucose-Regulated Glucagon Secretion and Impaired Counterregulation in Type 2 Diabetes
Quan Zhang et al.
CELL METABOLISM (2013)
Glucose Control of Glucagon Secretion: There Is More to It Than KATP Channels
Erik Gylfe
DIABETES (2013)
Glucagon increases circulating fibroblast growth factor 21 independently of endogenous insulin levels: a novel mechanism of glucagon-stimulated lipolysis?
A. M. Arafat et al.
DIABETOLOGIA (2013)
Hypothalamic glucagon signaling inhibits hepatic glucose production
Patricia I. Mighiu et al.
NATURE MEDICINE (2013)
Emerging combinatorial hormone therapies for the treatment of obesity and T2DM
Sharon A. Sadry et al.
NATURE REVIEWS ENDOCRINOLOGY (2013)
Mechanisms of Hypoglycemia-Associated Autonomic Failure in Diabetes
Philip E. Cryer
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Early Loss of the Glucagon Response to Hypoglycemia En Adolescents With Type 1 Diabetes
Aris Siafarikas et al.
DIABETES CARE (2012)
Blood Glucose Control in Type 1 Diabetes With a Bihormonal Bionic Endocrine Pancreas
Steven J. Russell et al.
DIABETES CARE (2012)
Sleep, Glucose, and Daytime Functioning in Youth with Type 1 Diabetes
Michelle M. Perfect et al.
SLEEP (2012)
Metabolic and physiologic effects of an endotoxin challenge in healthy obese subjects
Marcel Rohrer et al.
CLINICAL PHYSIOLOGY AND FUNCTIONAL IMAGING (2011)
Effects of Acute Hyperglucagonemia on Hepatic and Intestinal Lipoprotein Production and Clearance in Healthy Humans
Changting Xiao et al.
DIABETES (2011)
Closed-loop insulin delivery: from bench to clinical practice
Roman Hovorka
NATURE REVIEWS ENDOCRINOLOGY (2011)
Paradoxical Regulation of Human FGF21 by Both Fasting and Feeding Signals: Is FGF21 a Nutritional Adaptation Factor?
Takashi Uebanso et al.
PLOS ONE (2011)
Inappropriate glucagon response after oral compared with isoglycemic intravenous glucose administration in patients with type 1 diabetes
Kristine J. Hare et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2010)
Pathogenesis of Fasting and Postprandial Hyperglycemia in Type 2 Diabetes: Implications for Therapy
Robert A. Rizza
DIABETES (2010)
Glucagon regulation of energy metabolism
Kristy M. Heppner et al.
PHYSIOLOGY & BEHAVIOR (2010)
A Bihormonal Closed-Loop Artificial Pancreas for Type 1 Diabetes
Firas H. El-Khatib et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
Blunted Counterregulatory Hormone Responses to Hypoglycemia in Young Children and Adolescents With Well-Controlled Type 1 Diabetes
Eva Tsalikian et al.
DIABETES CARE (2009)
β-Cell-Mediated Signaling Predominates Over Direct α-Cell Signaling in the Regulation of Glucagon Secretion in Humans
Benjamin A. Cooperberg et al.
DIABETES CARE (2009)
Glucose Generates Coincident Insulin and Somatostatin Pulses and Antisynchronous Glucagon Pulses from Human Pancreatic Islets
Bo Hellman et al.
ENDOCRINOLOGY (2009)
The Glucagon Receptor Is Required for the Adaptive Metabolic Response to Fasting
Christine Longuet et al.
CELL METABOLISM (2008)
Glucagon receptors
F. Authier et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2008)
Pancreatic α-cell dysfunction in diabetes
R. Burcelin et al.
DIABETES & METABOLISM (2008)
Too much glucagon, too little insulin - Time course of pancreatic islet dysfunction in new-onset type 1 diabetes
Rebecca J. Brown et al.
DIABETES CARE (2008)
Orexin-A inhibits glucagon secretion and gene expression through a Foxo1-dependent pathway
Eva Goencz et al.
ENDOCRINOLOGY (2008)
Physiology of the pancreatic alpha-ce glucose secretion: role in glucose homeostasis and diabetes
Ivan Quesada et al.
JOURNAL OF ENDOCRINOLOGY (2008)
A KATP channel-dependent pathway within α cells regulates glucagon release from both rodent and human islets of langerhans
Patrick E. MacDonald et al.
PLOS BIOLOGY (2007)
α-Cells of the endocrine pancreas:: 35 years of research but the enigma remains
Jesper Gromada et al.
ENDOCRINE REVIEWS (2007)
Treatment of poisoning caused by β-adrenergic and calcium-channel blockers
Greene Shepherd
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2006)
Mini-dose glucagon rescue for mild hypoglycaemia in children with type 1 diabetes: The Brisbane experience
M Hartley et al.
JOURNAL OF PAEDIATRICS AND CHILD HEALTH (2006)
Impact of glucagon response on postprandial hyperglycemia in men with impaired glucose tolerance and type 2 diabetes mellitus
E Henkel et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2005)
Evidence of hepatic glucagon resistance associated with hepatic steatosis: Reversal effect of training
A Charbonneau et al.
INTERNATIONAL JOURNAL OF SPORTS MEDICINE (2005)
Mishandling of the therapeutic peptide glucagon generates cytotoxic amyloidogenic fibrils
S Onoue et al.
PHARMACEUTICAL RESEARCH (2004)
Passage of VIP/PACAP/secretin family across the blood-brain barrier: Therapeutic effects
D Dogrukol-Ak et al.
CURRENT PHARMACEUTICAL DESIGN (2004)
Glucagon and regulation of glucose metabolism
GQ Jiang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2003)
Interactions between hypoglycemia and sleep architecture in children with type 1 diabetes mellitus
G Pillar et al.
JOURNAL OF PEDIATRICS (2003)
Glucose regulates the release of orexin-A from the endocrine pancreas
R Ouedraogo et al.
DIABETES (2003)
Glucagon in beta-blocker and calcium channel blocker overdoses: A systematic review
B Bailey
JOURNAL OF TOXICOLOGY-CLINICAL TOXICOLOGY (2003)
Safety and efficacy of glucagon as a premedication for upper gastrointestinal endoscopy - a comparative study, with butyl scopolamine bromide
T Hashimoto et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2002)
Hypoglycemia-associated autonomic failure in advanced type 2 diabetes
SA Segel et al.
DIABETES (2002)
An audit of 500 subcutaneous glucagon stimulation tests to assess growth hormone and ACTH secretion in patients with hypothalamic-pituitary disease
KS Leong et al.
CLINICAL ENDOCRINOLOGY (2001)
Effects of short-term improvement of insulin treatment and glycemia on hepatic glycogen metabolism in type 1 diabetes
MG Bischof et al.
DIABETES (2001)
分享论文
